MBK Partners Acquires Alinamin Pharmaceutical
MBK Partners acquired Alinamin Pharmaceutical for $2.2B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- MBK Partners
- Acquired Company
- Alinamin Pharmaceutical
- Price
- $2.2B
- Acquisition Type
- Acquisition
- Announced
- July 1, 2024
Canonical: https://fsome.com/acquisitions/mbk-partners-acquires-alinamin-pharmaceutical-8085125 · For the full deal terms, timeline, and press references, please enable JavaScript.